A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Quinethazone
Epicaptopril
Epicaptopril may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Thioproperazine
Thioproperazine may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Acepromazine
Acepromazine may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Periciazine
Periciazine may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Phendimetrazine
Phendimetrazine may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Chlorphentermine
Chlorphentermine may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Tenamfetamine
Tenamfetamine may decrease the antihypertensive activities of Aliskiren.
Quinethazone
4-Bromo-2,5-dimethoxyamphetamine
4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Aliskiren.
Quinethazone
4-Methoxyamphetamine
4-Methoxyamphetamine may decrease the antihypertensive activities of Aliskiren.
Quinethazone
2,5-Dimethoxy-4-ethylamphetamine
2,5-Dimethoxy-4-ethylamphetamine may decrease the antihypertensive activities of Aliskiren.
Quinethazone
MMDA
MMDA may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Bambuterol
Bambuterol may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Clenbuterol
Clenbuterol may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Methotrimeprazine
Methotrimeprazine may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Procaterol
Procaterol may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Mephentermine
Mephentermine may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Ephedra sinica root
Ephedra sinica root may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Obinutuzumab
Aliskiren may increase the hypotensive activities of Obinutuzumab.
Quinethazone
Dexmethylphenidate
Dexmethylphenidate may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Candesartan
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Candesartan.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3